$205.22
25.6414.28%
Last update: Nov 4, 7:59 PM

Nutex Health (NUTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Nutex Health (NUTX) last issued guidance on August 14, 2025 for Q2 2025. The company guided revenue in the range of $244M - $244M for the period.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $5.54 | $5.03 | $5.56 | $5.56 |
| Actual | — | $9.38 | $6.52 | $1.61 |
| Surprise | — | +86.5% | +17.3% | -71.0% |
| Revenue | ||||
| Estimate | $215.2M | $216.0M | $227.8M | $258.8M |
| Actual | — | $210.8M | $216.5M | $151.7M |
| Surprise | — | -2.44% | -4.97% | -41.4% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $5.99 | $7.57 | $6.86 |
| Revenue | |||
| Consensus | $228.5M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $9.38 | $5.03 | 86.5 % |
| Q1 | Apr 30, 2026 | $6.52 | $5.56 | 17.3 % |
| Q4 | Mar 5, 2026 | $1.61 | $5.56 | -71.0 % |
| Q3 | Nov 19, 2025 | $7.76 | $1.95 | 297.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $210.75M | $216.02M | -2.44 % |
| Q1 | Apr 30, 2026 | $216.49M | $227.80M | -4.97 % |
| Q4 | Mar 5, 2026 | $151.68M | $258.82M | -41.4 % |
| Q3 | Nov 19, 2025 | $267.80M | $213.81M | 25.3 % |